Use of OB-101 to treat ocular inflammation

dc.creator	Chiou, George C. Y.
dc.date.accessioned	2019-07-12T20:48:11Z
dc.date.available	2019-07-12T20:48:11Z
dc.date.issued	1993-03-16
dc.identifier.uri	https://hdl.handle.net/1969.1/177526
dc.description.abstract	A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of inflammation in both the anterior and posterior portions of the eye.	en
dc.language	eng
dc.publisher	United States. Patent and Trademark Office
dc.rights	Public Domain (No copyright - United States)	en
dc.rights.uri	http://rightsstatements.org/vocab/NoC-US/1.0/
dc.title	Use of OB-101 to treat ocular inflammation	en
dc.type	Utility patent	en
dc.format.digitalOrigin	reformatted digital	en
dc.description.country	US
dc.contributor.assignee	Texas A&M University System
dc.identifier.patentapplicationnumber	07/801891
dc.subject.uspcprimary	514/227.2
dc.subject.uspcother	424/427
dc.subject.uspcother	514/912
dc.date.filed	1991-12-03
dc.publisher.digital	Texas A&M University. Libraries
dc.subject.cpcprimary	A61K 31/54
dc.subject.cpcprimary	Y10S 514/912